EKTOPIK GEBELIKTE MEDIKAL YAKLASIM

Year 2001, Volume: 54 Issue: 3, 233 - 240, 30.09.2001

Yusuf Üstün

https://izlik.org/JA24HD48AE

Abstract

Gtindmuzde ektopik gebeligin tedavisi degismis, konservatif yaklasim 6n plana gecmistir. Ektopik gebeligi olan pek cok kadin cerrahi yerine metotreksat ile tedavi edilmektedir. Randomize calismalar uygun vakalarda metotreksat ile tedavinin laparoskopik cerrahi kadar etkili oldugunu géstermektedir. Bununla birlikte medikal ve cerrahi tedavinin yasam kalitesi Uzerine olan etkileri karsilastirilmalidir. Genel olarak metotreksat ile medikal tedavi cerrahi yaklasima gére daha ekonomiktir.
Metotreksat ile tedavi edilen tim hastalar serumda hCG defgerleri Negatiflesene kadar yakindan takip edilmelidir. Baslangig serum hCG konsantrasyonu metotreksat protokoltiyle tedavi edilen hastalarda
tedavi basarisini gésteren en iyi prognostik faktérdir,

Keywords

Ektopik Gebelik , Medikal Tedavi , Metotreksat

MEDICAL APPROACH TO ECTOPIC PREGNANCY

https://izlik.org/JA24HD48AE

Abstract

The management of ectopic pregnancy has
changed dramatically over the years and a conservative approach now predominates. Many women
with ectopic pregnancies are now treated with
methotrexate instead of surgery. Randomized
studies have demonstrated that in selected cases
medical treatment with methotrexate is as effective
as laparoscopic surgery. However, medical treatment might have a more negative impact of
patients health-related quality of life than surgical
treatment. In general, medical treatment with
methotrexate is less costly than the surgical
approach, All patients treated with methotrexate
should be followed up closely until hCG is no
longer detectable in the serum. The initial serum
hCG concentration is the best prognostic indicator
of treatment success in women with ectopic pregnancies who are treated according to methotrexate
protocol.

Keywords

Ectopic Pregnancy , Medical Management , Methotrexate.

Ethical Statement

-

References

• 1- Buster JE, Pisarska MD. Medical management of ectopic pregnancy. Clin Obstet Gynecol 1999;42: 23-30.
• 2- Ballen AH, Jacobs HS, DeCherney AH (eds), Ectopic Pregnancy. In: Infertility in practice. Churchill Livingstone 1997: 361.
• 3- Lipscomb GH. Ectopic Pregnancy. In: Copeland LJ editor, Textbook of gynecology 2nd ed WB Saunders Company 2000: 273-86
• 4- Maheux R. Ectopic pregnancy. In: Decherney AH,Polan ML (eds), Reproductive surgery. Chicago:Year Book Medical Publishers, 1987: 243.
• 5- Marchbank PA, Annegers JF, Coulam JB. Risk factors for ectopic pregnancy: a population-based study. JAMA 1988; 259: 1823.
• 6- Ankum WM, Mol BW], Van der Veen F, Bossuyt PMM. Risk factors for ectopic pregnancy metaanalysis. Fertil Steril 1996; 65: 1093.
• 7- Tulandi T. Current protocol for ectopic pregnancy. Contemp Obstet Gynecol! 1999; 44: 42-55.
• 8- Speroff L, Glass RH, Kase NG (eds). Ectopic pregnancy. In: Clinical gynecologic endocrinology and infertility. Lippincott William&Wilkins 6th ed 1999: 1154.
• 9- Weinstein LN. Current perspective on ectopic pregnancy. Obstet Gynecol Surv 1985; 40: 259.
• 10- Graczykowski JW, Seifer DB. Diagnosis of acute and persistent ectopic pregnancy. Clin Obstet Gynecol 1999; 42: 9-22.
• 11- Romero R, Kadar H, Castro D. The value of serial CG testing as a diagnostic tool in ectopic pregnancy. Am J Obstet Gynecol 1986; 155: 392.
• 12- Maccato ML, Estrada R, Faro S. Ectopic pregnancy with undetectable serum and urine (-hCG levels and detection of (-hCG in the ectopic trophoblast by immunocytochemical evaluation. Obstet Gynecol 1993; 81: 878-80.
• 13- Vermesh M, Silva PD, Sauer MV, Vargyas JM, Lobo RA. Persistent tubal ectopic gestation: patterns of circulating (-hCG and progesterone and management options. Fertil teril 1988; 50:784-88.
• 14- Kadar N, Bohrer M, Kemman E, Shelden R. The discriminatory hCG zone for endovaginal sonography: a prospective, randomized study. Fertil Steril 1994; 61: 1016-20.
• 15- McCord M, Muram D, Buster JE, Arheart KL, Stoval TG, Carson SA. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance. Fertil Steril 1996; 66: 513-6.
• 16- Seifer DB, Lambert-Messerlian G, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Ferti! Steril 1996; 65: 667-9.
• 17- Duncan WC, Sweeting VM, Cawood P, Illingworth P]. Measurement of creatine kinase activity and diagnosis of ectopic pregnancy. Br J Obstet Gynecol 1995; 102: 233-7.
• 18- Saha PK, Gupta I, Ganguly NK. Evaluation serum creatinin kinase as a diagnostic marker for tubal pregnancy. Aust NZ J Obstet Gynaecol 1999; 39: 366-7.
• 19- Nowacek GE, Meyer WR, McMahon MJ et al. Diagnostic value of cervical fetal fibronectin in detecting extrauterine pregnancy. Fertil Steril 1999; 72: 302-4.
• 20- Daniel Y Geva E, Lerner-Geva L. Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy. Fertil Steril 1999; 72: 1013-7.
• 21- Pisarska Carson SA, Buster JE. Ectopic pregnancy. Lancet 1998; 351: 1115-20.
• 22- Chu E, Drake JC, Boarman D, Baram J, Allegra CJ. Mechanism of thymidylate synthase inhibition by methotrexate. J Biol Chem 1990; 265: 8470- 8.
• 23- Barnhart K, Esposito M, Coutifaris C. An update on the medical treatment of ectopic pregnancy. Obstet Gynecol Clin North Am 2000; 27: 653- 67.
• 24- Floridon C, Thomsen SG. Methotrexate treatmen of ectopic pregnancy. Acta Obstet Gynecol Scand 1994; 73: 746-52.
• 25- Goldenberg M, Bider D, Admon D. Methotrexate therapy of tubal pregnancy. Hum Reprod 1993; 8: 660-6.
• 26- Timor-Tritsch IE, Yeh MN, Peisner DB. The use of transvaginal ultrasound in the diagnosis of ectopic pregnancy. Am J Obstet Gynecol 1988; 161: 157-61.
• 27- Mol B, Hajenius P, Ankum W. Screening for ectopic pregnancy in symptom-free women at increased risk. Obstet Gynecol 1997; 89: 704- 7.
• 28- Stovall TG, Ling FW. Single dose methotrexate: an “expanded ‘Clinical trial’ Am J Obstet Gynécol 1993; 168: 1759-65.
• 29- Powell MP, Spellman JR Medical management of the patient with an ectopic pregnancy. J Perinat Neonatal Nurs 1996 Mar;9(4):31-43.
• 30- Lipscomb GH, Bran D, McCord ML, Portera JC, Ling FW Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet ynecol 1998 JUN;178(6):1354-8.
• 31- Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl } Med,1999; 341: 1974-8.
• 32- Gazvani MR, Baruah DN, Alfirevic Z, Emery SJ. Mifepristone in combination with methotrexate for the medical treatment of tubal pregnancy: a randomized controlled trial. Hum Reprod 1998; 13: 1987-90.
• 33- Tulandi T, Sammour A. Evidence-based management of ectopic pregnancy. Curr opin Obstet Gynecol 2000; 12: 289-92,
• 34- Risquez F, Foreman R, Maleika F, Foulot H et al. Transcervical cannulation of the fallopian tube for the management of ectopic pregnancy: Prospective multicenter study. Fertil Steril. 1992; 58: 1131-1135.
• 35- American College of Obstetricians and Gynecologists: Medical management of Tubal Pregnancy. Whashington, DC, ACOG, 1998; Practice Bulletin No.3.
• 36- Kooni GS, Kock HC. A review of the literature on nonsurgical treatment in tubal pregnancies. Obstet Gynecol Surv 1992; 47: 739-49.
• 37- Isaacs JD, McGehee RP, Cowan BD. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: A report of two cases. Obstet Gynecol 1996; 88: 694-6.
• 38- Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gynecol 1997; 176: 714-5,
• 39- Schoenfeld A, Mashiach R, Vardy M, Ovadia J. Methotrexate pneumonitis in the non-surgical treatment of ectopic pregnancy. Obstet — ..—Gynecol-1992;-80:520-1.-
• 40- Brown DL, Felker RE, Stowal TG et al. Serial endovaginal sonography of ectopic pregnancies treated with methotrexate. Obstet Gynecol 1991; 77: 406.